Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
National Brazilian survey on the outcomes of hepatitis c retreatment in patients non-responders to direct antiviral agents.
Ferraz MLG, Piccoli LZ, Rezende R, Borba LA, Junior AP, Cheinquer H, Silva GF, Ferreira PRA, Villela-Nogueira CA, Mazo DF, Souza FF, Codes L, Ivantes CAP, Gomide GPM, Pereira GHS, Pessôa MG, França AVC, Pinto ADS, Teixeira R, Bittencourt PL. Ferraz MLG, et al. Among authors: teixeira r. Braz J Infect Dis. 2022 Jul-Aug;26(4):102388. doi: 10.1016/j.bjid.2022.102388. Epub 2022 Jul 26. Braz J Infect Dis. 2022. PMID: 35905930 Free PMC article.
Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin ± amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial.
Pessôa MG, Cheinquer H, Almeida PR, Silva GF, Lima MP, Paraná R, Lacerda MA, Parise ER, Pernambuco JR, Pedrosa SS, Teixeira R, Sette H Jr, Tatsch F. Pessôa MG, et al. Among authors: teixeira r. Ann Hepatol. 2012 Jan-Feb;11(1):52-61. Ann Hepatol. 2012. PMID: 22166561 Free article. Clinical Trial.
HBV carrying drug-resistance mutations in chronically infected treatment-naive patients.
Gomes-Gouvêa MS, Ferreira AC, Teixeira R, Andrade JR, Ferreira AS, Barros LM, Rezende RE, Nastri AC, Leite AG, Piccoli LZ, Galvan J, Conde SR, Soares MC, Kliemann DA, Bertolini DA, Kunyoshi AS, Lyra AC, Oikawa MK, de Araújo LV, Carrilho FJ, Mendes-Corrêa MC, Pinho JR. Gomes-Gouvêa MS, et al. Among authors: teixeira r. Antivir Ther. 2015;20(4):387-95. doi: 10.3851/IMP2938. Epub 2015 Jan 27. Antivir Ther. 2015. PMID: 25624410
HEPATITIS C IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM: BURDEN OF DISEASE.
Castelo A, Mello CEB, Teixeira R, Madruga JVR, Reuter T, Pereira LMMB, Silva GF, Álvares-DA-Silva MR, Zambrini H, Ferreira PRA. Castelo A, et al. Among authors: teixeira r. Arq Gastroenterol. 2018 Oct-Dec;55(4):329-337. doi: 10.1590/S0004-2803.201800000-74. Arq Gastroenterol. 2018. PMID: 30785514 Free article.
Remodeling of immunological biomarkers in patients with chronic hepatitis C treated with direct-acting antiviral therapy.
Ribeiro IG, Coelho-Dos-Reis JGA, Fradico JRB, Costa-Rocha IAD, Silva LD, Fonseca LADS, Stancioli RCS, Teixeira-Carvalho A, Martins-Filho OA, Teixeira R. Ribeiro IG, et al. Among authors: teixeira r, teixeira carvalho a. Antiviral Res. 2021 Jun;190:105073. doi: 10.1016/j.antiviral.2021.105073. Epub 2021 Apr 19. Antiviral Res. 2021. PMID: 33887350
1,175 results